LIPOPROTEINS CONTAINING APOLIPOPROTEIN A-IV - COMPOSITION AND RELATION TO CHOLESTEROL ESTERIFICATION

被引:15
|
作者
DUVERGER, N [1 ]
GHALIM, N [1 ]
THERET, N [1 ]
FRUCHART, JC [1 ]
CASTRO, G [1 ]
机构
[1] INST PASTEUR, INSERM, U325, F-59019 LILLE, FRANCE
来源
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM | 1994年 / 1211卷 / 01期
关键词
LIPOPROTEIN; APO A-I; APO A-II; APO A-IV; LCAT; CHOLESTEROL ESTERIFICATION; SPHINGOMYELIN; PHOSPHATIDYLCHOLINE; FATTY ACID COMPOSITION;
D O I
10.1016/0005-2760(94)90134-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In order to investigate the relationship of lipid and apolipoprotein composition to cholesterol esterification in lipoproteins containing apolipoprotein (ape) A-IV, apo A-containing lipoprotein particles were isolated from fresh human plasma using a system of sequential immunoaffinity chromatography. Plasma was first depleted of apo B- and apo E-containing lipoproteins. Four major subpopulations of ape A-containing lipoprotein particles were separated: Lp A-I, Lp A-I:A-II, Lp A-IV and Lp A-I:A-IV:A-II. Lp A-IV and Lp A-I:A-IV:A-II contained less total lipid, less cholesterol and more triacylglycerol than Lp A-I and Lp A-I:A-II. Lp A-IV and Lp A-I:A-IV:A-II contained more sphingomyelin and less phosphatidylcholine than Lp A-I and Lp A-I:A-II and were richer in (16:0 +/- 18:0) saturated fatty acids. Among these isolated lipoprotein particles, Lp A-IV contained the highest lecithin: cholesterol acyltransferase (LCAT) activity per mu g of protein. Cholesterol esterification rates were 2.6 +/- 0.5, 5.3 +/- 0.4 and 0.8 +/- 0.2 mu mol of cholesterol per hour per m,a of lipoproteins for Lp A-IV, Lp A-I and Lp A-I:A-II, respectively. The apolipoprotein and lipid composition and LCAT activity of Lp A-IV suggest that this lipoprotein may be a source of cholesterol esterification in plasma.
引用
收藏
页码:23 / 28
页数:6
相关论文
共 50 条
  • [31] Hypothalamic apolipoprotein A-IV is regulated by leptin
    Shen, Ling
    Tso, Patrick
    Woods, Stephen C.
    Sakai, Randall R.
    Davidson, W. Sean
    Liu, Min
    ENDOCRINOLOGY, 2007, 148 (06) : 2681 - 2689
  • [32] Inhibition of Vascular Inflammation by Apolipoprotein A-IV
    Shearston, Kate
    Tan, Joanne T. M.
    Cochran, Blake J.
    Rye, Kerry-Anne
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [33] Apolipoprotein A-IV inhibits experimental colitis
    Vowinkel, T
    Mori, M
    Krieglstein, CF
    Russell, J
    Saijo, F
    Bharwani, S
    Turnage, RH
    Davidson, WS
    Tso, P
    Granger, DN
    Kalogeris, TJ
    JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02): : 260 - 269
  • [34] Apolipoprotein A-IV enhances cholecystokinnin secretion
    Zhan, Jesse
    Weng, Jonathan
    Hunt, Brian G.
    Davidson, W. Sean
    Liu, Min
    Le, Chunmin C.
    PHYSIOLOGY & BEHAVIOR, 2018, 188 : 11 - 17
  • [35] Apolipoprotein A-IV Associated Cardiac Amyloidosis
    Bois, Melanie C.
    Dasari, Surendra
    Theis, Jason D.
    Vrana, Julie
    Grogan, Martha
    Dispenzieri, Angela
    Kurtin, Paul J.
    Maleszewski, Joseph J.
    LABORATORY INVESTIGATION, 2016, 96 : 81A - 82A
  • [36] Apolipoprotein A-IV in the fed and fasting states
    Rafat, N
    Sattler, AM
    Hackler, R
    Soufi, M
    Steinmetz, A
    Maisch, B
    Schaefer, JR
    CLINICAL CHEMISTRY, 2004, 50 (07) : 1270 - 1271
  • [37] Gastrointestinal satiety signals - IV. Apolipoprotein A-IV
    Tso, P
    Sun, W
    Liu, M
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2004, 286 (06): : G885 - G890
  • [38] APOLIPOPROTEIN A-IV IN DIABETES-MELLITUS
    VERGES, B
    DIABETES & METABOLISM, 1995, 21 (02): : 99 - 105
  • [39] PLASMA APOLIPOPROTEIN A-IV AND LIPOPROTEIN CHOLESTEROL IN PATIENTS UNDERGOING TOTAL PARENTERAL-NUTRITION
    SHERMAN, JR
    WEINBERG, RB
    GASTROENTEROLOGY, 1987, 92 (05) : 1805 - 1805
  • [40] Severe experimental colitis in apolipoprotein A-IV knockout mice can be prevented with recombinant human apolipoprotein A-IV treatment
    Vowinkel, T
    Kalogeris, TJ
    Krieglstein, CF
    Mori, M
    Turnage, RH
    Tso, P
    Granger, DN
    GASTROENTEROLOGY, 2004, 126 (04) : A283 - A283